दवाओं की अंतःक्रिया
Insulin degludec-insulin aspart + Rosiglitazone
गंभीरता: गंभीर
Insulin degludec-insulin aspart and Rosiglitazone: major interaction.
अंतिम अपडेट
केवल स्वास्थ्य पेशेवरों के लिए — मात्र संदर्भ हेतु। यह पृष्ठ संक्षिप्त सारांश है, चिकित्सकीय सलाह नहीं है और आधिकारिक लेबल या नैदानिक निर्णय का विकल्प नहीं है। दवा लिखने या देने से पहले हमेशा जाँच करें।
इस पृष्ठ की नैदानिक सामग्री केवल अंग्रेज़ी में उपलब्ध है।
सारांश
Rosiglitazone combined with insulin increases glucose lowering and the risk of hypoglycemia. The combination markedly raises the risk of edema and heart failure, and labeling advises against its use with insulin.
इस इंटरैक्शन का सरल भाषा में अर्थ
Insulin degludec-insulin aspart and Rosiglitazone can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Insulin degludec-insulin aspart belongs to Endocrine; Rosiglitazone belongs to Endocrine.
ऐसा क्यों होता है
Rosiglitazone increases insulin sensitivity and causes fluid retention, adding to insulin effect and cardiac volume load.
क्या करें
Avoid combining where possible; if used, reduce insulin as needed and monitor for edema, weight gain and heart failure.
फार्मासिस्ट से क्या पूछें
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ सदस्यों के लिए
पूरा पेज खोलें
Insulin degludec-insulin aspart और Rosiglitazone की पूरी प्रबंधन सलाह, अतिरिक्त नोट्स, साक्ष्य का विवरण और पूरे पर्चे का इंटरैक्शन चेकर खोलने के लिए खाता बनाएँ और Pro+ ट्रायल शुरू करें।
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
वेब पर Pro+ को 14 दिन मुफ़्त आज़माएँ। कार्ड की ज़रूरत नहीं।
Insulin degludec-insulin aspart के अन्य इंटरैक्शन
- Chlorpropamide + Insulin degludec-insulin aspart गंभीर
- Clozapine + Insulin degludec-insulin aspart गंभीर
- Diazoxide + Insulin degludec-insulin aspart गंभीर
- Ethanol + Insulin degludec-insulin aspart गंभीर
- Insulin degludec-insulin aspart + Mecasermin गंभीर
- Insulin degludec-insulin aspart + Pioglitazone गंभीर
Rosiglitazone के अन्य इंटरैक्शन
- Insulin aspart protamine / insulin aspart + Rosiglitazone गंभीर
- Insulin aspart-insulin aspart protamine + Rosiglitazone गंभीर
- Insulin aspart + Rosiglitazone गंभीर
- Insulin degludec / insulin aspart + Rosiglitazone गंभीर
- Insulin degludec-liraglutide + Rosiglitazone गंभीर
- Insulin degludec + Rosiglitazone गंभीर
अक्सर पूछे जाने वाले प्रश्न
Can I take Insulin degludec-insulin aspart with Rosiglitazone?
MediHelp rates the interaction as major. Insulin degludec-insulin aspart and Rosiglitazone can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Rosiglitazone combined with insulin increases glucose lowering and the risk of hypoglycemia. The combination markedly raises the risk of edema and heart failure, and labeling advises against its use with insulin.
How serious is the interaction between Insulin degludec-insulin aspart and Rosiglitazone?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid combining where possible; if used, reduce insulin as needed and monitor for edema, weight gain and heart failure.
What other medicines interact with Insulin degludec-insulin aspart?
MediHelp also lists interactions of Insulin degludec-insulin aspart with, for example, Chlorpropamide, Clozapine, Diazoxide. The full list is on the Insulin degludec-insulin aspart page.
MediHelp ऐप में पूर्ण मोनोग्राफ़, खुराक और इंटरैक्शन चेकर
MediHelp ऐप में पूरा संदर्भ खोलें, कई दवाओं की अंतःक्रियाएँ जाँचें और खुराक टूल इस्तेमाल करें।
